Parkinson's Disease
Conference Coverage
Droxidopa May Reduce Neurogenic Orthostatic Hypotension Symptoms in Patients Taking DDCIs
MIAMI—Droxidopa is associated with reductions in fall risk and dizziness or lightheadedness among users and nonusers of dopamine decarboxylase...
Conference Coverage
Ch4 Density Is a Potential Imaging Biomarker of Cognition in Early Parkinson’s Disease
MIAMI—Reduced cholinergic nucleus 4 (Ch4) density in Parkinson’s disease, as measured with MRI, is associated with deficits in attention,...
Conference Coverage
Strategies for Treating Motor Fluctuations in Parkinson’s Disease
MIAMI—Motor fluctuations in Parkinson’s disease can arise from more than one cause, and a clinician needs to consider a range of possibilities....
Conference Coverage
Lipid Metabolism May Be a Therapeutic Target in MS
NASHVILLE—Multiple sclerosis (MS) traditionally has been considered a chronic inflammatory autoimmune disease, but inflammation decreases as the...
Conference Coverage
What Are the Best Therapeutic Options for Parkinson’s Disease?
LOS ANGELES—Physicians who treat patients with Parkinson’s disease have many decisions to make based on therapeutic efficacy and...
Literature Review
Type 2 Diabetes Increases the Risk of Parkinson’s Disease
Patients with type 2 diabetes mellitus have an increased risk of developing Parkinson’s disease later in life, according to an investigation...
From the Journals
Type 2 diabetes may promote Parkinson development
Individuals with type 2 diabetes may be at increased risk of Parkinson’s disease in later life, particularly those who develop diabetes at a...
Conference Coverage
Can a Finger Displacement Test Help Assess Parkinson’s Disease Dementia?
LOS ANGELES—A simple test of finger displacement may distinguish between Parkinson’s disease dementia and Alzheimer’s disease and help...
Conference Coverage
Tear Proteins May Be Biomarkers for Parkinson’s Disease
LOS ANGELES—Tears may hold diagnostic clues as to whether someone has Parkinson’s disease, according to a preliminary study presented at the...
Conference Coverage
Staging System Classifies Nearly All Patients With Lewy Body Synucleinopathy
LOS ANGELES—The Unified Staging System for Lewy Body Disorders (USSLB) enables the categorization of almost all brains with Lewy body...
Conference Coverage
IncobotulinumtoxinA May Reduce Sialorrhea in Parkinson’s Disease
LOS ANGELES—IncobotulinumtoxinA may treat sialorrhea in Parkinson’s disease and other neurologic disorders effectively, according to a trial...